Scientists develop first-ever ‘smell map’ of receptors in noses

By Stephen Beech

The first-ever "smell map" has been created to sniff out exactly how the sense works.

The detailed diagram of receptors in the nose could lead to better treatments for people who have lost their sense of smell, say scientists.

The map now matches similar achievements in sight, hearing and touch.

It reveals that hundreds of smell receptors in the nose are "highly organized" into tight bands based on type.

The American research team say their findings, published in the journal Cell, provide "foundational knowledge" needed to develop better therapies for loss of smell.

For most of us, the sense of smell plays a critical role in providing information about our surroundings, alerting us to potential dangers, enhancing our sense of taste, and evoking emotions and memories.

But, from a scientific perspective, Professor Sandeep Datta at Harvard Medical School said "olfaction is super-mysterious" with basic biological understanding lagging behind that of vision, hearing, and touch.

Working in mice, study senior author Datta and his team have now created the first detailed map of how the thousand-plus types of smell receptors in the nose are organized.

They discovered that unlike what researchers had previously believed, the neurons expressing the receptors have a high degree of spatial organization: they form horizontal stripes based on receptor type from the top of the nose to the bottom.

Datta, of the Blavatnik Institute at Harvard Medical School, Boston, said: "Our results bring order to a system that was previously thought to lack order, which changes conceptually how we think this works."

The research team established that the receptor map in the nose matches up with smell maps in the olfactory bulb of the brain, providing clues about how information moves from the nose to the brain.

Datta said that while the smell map is an "exciting" discovery in its own right, it also provides foundational information that could help scientists develop therapies for loss of smell.

He said: "We cannot fix smell without understanding how it works on a basic level."

Datta explained that maps have long existed that describe how receptors in the eye, ear, and skin are organized to capture and interpret auditory, visual, and touch information.

Scientists have also worked out how the maps correspond with those inside the brain.

But Datta said: "Olfaction has been the one exception; it's the sense that has been missing a map for the longest time."

He says that is in part because it is more complicated than the other senses.

For example, mice have around 20 million olfactory neurons that express more than a thousand types of smell receptors, compared with only three main types of visual receptors for color vision.

Each type of smell receptor detects a unique subset of odor molecules.

More from this section

From pregnancy to baby’s first year: How Medicaid supports parent and infant care

Seniors reveal reality of memory loss and how to avoid it

Your body already has a built-in weight loss system that works like Wegovy, Ozempic and Mounjaro – food and your gut microbiome

Scientists first began identifying smell receptor types in 1991.

Since then, researchers have investigated whether there was a smell map in the nose.

However, they could only observe that receptors tended to be expressed in one of a handful of zones in olfactory tissue.

That led to the prevailing theory that receptor expression was largely random, meaning that smell was unlike the other senses.

Datta had been studying various aspects of olfaction, including what causes loss of smell in COVID-19 and how the brain organizes information about odors.

As genetic techniques became more powerful, he and colleagues decided to revisit the idea of building a smell map.

For the new study, the research team combined single-cell sequencing and spatial transcriptomics techniques to examine around 5.5 million neurons in more than 300 individual mice.

The first technique allowed them to identify which smell receptors were expressed by neurons in the nose, and the second let them determine the locations of those receptors.

Datta said: "This is now arguably the most sequenced neural tissue ever, but we needed that scale of data in order to understand the system."

The team discovered that the neurons are organized into tight, overlapping, horizontal stripes from the top of the nose to the bottom based on the type of smell receptor they express.

They said the highly organized receptor map was consistent across the mice and mirrored the organization of smell maps in the brain, just like researchers have observed in vision, hearing, and touch.

The research team then investigated how the smell map in the nose forms and identified retinoic acid — a molecule that helps control gene activity — as a key driver.

They found that a gradient of retinoic acid in the nose guided each neuron to express the correct type of smell receptor based on its spatial location.

Adding or removing retinoic acid caused the receptor map to shift up or down.

Datta said: "We show that development can achieve this feat of organizing a thousand different smell receptors into an incredibly precise map that's consistent across animals."

A separate study led by the Harvard lab of Professor Catherine Dulac, published in the same issue of Cell, had consistent findings.

Now, the researchers are exploring why the receptor stripes are in a specific order.

The team is also studying smell receptors in human tissue to understand to what degree the smell map is consistent across species.

They say such understanding will aid efforts to develop treatments — such as stem cell therapies or brain-computer interfaces — for loss of smell and its consequences, which include an increased risk of depression.

Datta said: "Smell has a really profound and pervasive effect on human health, so restoring it is not just for pleasure and safety but also for psychological well-being."

He added: "Without understanding this map, we're doomed to fail in developing new treatments."